Novavax Shares Are Trading Higher on Continued Strength. The Company Last Week Announced a Co-exclusive Licensing Agreement With Sanofi to Commercialize a COVID-19 Vaccine and Develop COVID-influenza Combination Vaccines.
Novavax Shares Are Trading Higher on Continued Strength. The Company Last Week Announced a Co-exclusive Licensing Agreement With Sanofi to Commercialize a COVID-19 Vaccine and Develop COVID-influenza Combination Vaccines.
在持續走強的情況下，Novavax的股價正在走高。該公司上週宣佈與賽諾菲簽訂共同獨家許可協議，將 COVID-19 疫苗商業化並開發COVID-流感複合疫苗。
Novavax Shares Are Trading Higher on Continued Strength. The Company Last Week Announced a Co-exclusive Licensing Agreement With Sanofi to Commercialize a COVID-19 Vaccine and Develop COVID-influenza Combination Vaccines.
在持續走強的情況下，Novavax的股價正在走高。該公司上週宣佈與賽諾菲簽訂共同獨家許可協議，將 COVID-19 疫苗商業化並開發COVID-流感複合疫苗。
譯文內容由第三人軟體翻譯。
以上內容僅用作資訊或教育之目的，不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。